The currently prevailing trends in industrial contrast agent research
for MRI are discussed. Specific mention is made of contrast agents for
liver imaging using both static and delayed procedures, of the potent
ial for blood pool agents and the form such agents may take, and of th
e ultimate challenge for contrast agent R&D: tissue-targeting in a wid
er sense to both normal and pathologic tissues.